Abstract Details

Title Autoimmune Tumefactive Rhombencephalitis Associated with Anti-TNFα (Adalimumab) Treatment

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 017

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Kedar Mahajan, MD, PhD PRESENTER	Dr. Mahajan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Mahajan has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech.
Omar S. Shah, MD (Thomas Jefferson University)	No disclosure on file

��ɫ����